Meclizine Tablet, Chewable
FDA Label NDC 43063-804

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pd-rx Pharmaceuticals, Inc. for the product Meclizine (NDC 43063-804). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients (in each chewable tablet), purpose, indications and usage, warnings, do not take unless directed by a doctor if you have, otc - ask doctor/pharmacist, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Purpose

Antiemetic

Indications And Usage

prevents and treats nausea, vomiting, dizziness associated with motion sickness:

Warnings

  • Do not use for children under 12 years of age unless directed by a doctor.

Do Not Take Unless Directed By A Doctor If You Have

  • glaucoma
  • trouble urinating due to an enlarged prostate gland
  • a breathing problem such as emphysema or chronic bronchitis

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding,

  • ask health professional before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

Directions

Dosage should be taken 1 hour befor travel starts.

Adults and children 12 years and over:Take 1 or 2 tablets once daily, or as directed by doctor.

Questions?

Adverse drug event call (866) 562-2756 (M-F, 8AM-4PM EST).

* Please review the disclaimer below.